Our Focus
Pipeline
- CardiolRx™
- CRD-38
Clinical Trials
Company
Insights
Investors

MAVERIC: Pivotal Phase 3 Trial in Recurrent Pericarditis

<br />

Join our newsletter

Sign up to receive the latest news from Cardiol Therapeutics!

By subscribing you agree to with our Privacy Policy

Name(Required)

First Last

Email(Required)

CAPTCHA

Company
Our Focus
Pipeline
Insights
Investors

2026 Cardiol Therapeutics. All right reserved.